Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05308004 · ClinicalTrials.gov registry record · NA
Palliative Care for Persons With ADRD and CI in SNF
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT05308004 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 7 participants.
The verdict
NCT05308004, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Alzheimer's disease and related dementias (ADRD) are serious, life limiting illnesses with no known cure. Dementia is the fifth-leading cause of death in older adults and the majority of people with advanced dementia die in nursing homes (NHs). Miller et al reported that 40% of U.S. NH residents dying with advanced dementia received Skilled Nursing Facility (SNF) care in the last 90 days of life, and receipt of this care was associated significantly with poorer end-of-life outcomes, including a higher risk of dying in a hospital, compared to decedents with no SNF care. SNF care is a Medicare post-acute rehabilitation service delivered in NHs focused on intense rehabilitation and/or aggressive, disease-modifying therapies. Regardless of life expectancy, use of SNF care precludes access to Hospice services. Palliative care (PC) offers an evidence-based alternative.
Interventions
- OTHER Palliative Care Consultation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2023-12-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05308004
The ClinicalTrials.gov registry entry for NCT05308004 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Palliative Care Consultation is the first listed.
NCT05308004 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05308004 about?
NCT05308004 is a clinical study titled "Palliative Care for Persons With ADRD and CI in SNF". Alzheimer's disease and related dementias (ADRD) are serious, life limiting illnesses with no known cure. Dementia is the fifth-leading cause of death in older adults and the majority of people with advanced dementia die in nursing homes (NHs). Miller et al reported that 40% of U.S. NH residents dyi...
What is the current status of trial NCT05308004?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2022-06-15. Estimated completion is 2023-12-14.
What interventions are being tested in trial NCT05308004?
The interventions under investigation include: Palliative Care Consultation (OTHER).
Who is sponsoring clinical trial NCT05308004?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.